UiPath Inc. (NYSE:PATH – Get Free Report) CFO Ashim Gupta sold 47,227 shares of the business’s stock in a transaction that occurred on Friday, January 3rd. The stock was sold at an average price of $13.06, for a total transaction of $616,784.62. Following the sale, the chief financial officer now owns 856,538 shares of the company’s stock, valued at $11,186,386.28. This represents a 5.23 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
UiPath Price Performance
NYSE:PATH traded up $0.49 during trading hours on Monday, reaching $13.77. 17,155,609 shares of the company traded hands, compared to its average volume of 9,814,896. The firm’s 50-day moving average is $13.48 and its 200-day moving average is $12.72. The stock has a market cap of $7.57 billion, a P/E ratio of -86.06 and a beta of 0.96. UiPath Inc. has a 1-year low of $10.37 and a 1-year high of $27.87.
Analysts Set New Price Targets
Several brokerages have issued reports on PATH. UBS Group assumed coverage on shares of UiPath in a research report on Thursday, December 12th. They set a “sell” rating and a $14.00 price objective on the stock. Barclays raised their price target on UiPath from $15.00 to $16.00 and gave the company an “equal weight” rating in a report on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of UiPath in a report on Thursday, December 19th. JPMorgan Chase & Co. raised their target price on UiPath from $17.00 to $18.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Finally, Morgan Stanley upped their price target on shares of UiPath from $15.00 to $16.00 and gave the stock an “equal weight” rating in a research note on Friday, December 6th. One investment analyst has rated the stock with a sell rating, sixteen have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $17.50.
Institutional Trading of UiPath
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Commonwealth Equity Services LLC lifted its stake in shares of UiPath by 5.6% during the second quarter. Commonwealth Equity Services LLC now owns 107,468 shares of the company’s stock valued at $1,363,000 after buying an additional 5,742 shares during the period. Van ECK Associates Corp raised its holdings in UiPath by 266.5% in the 2nd quarter. Van ECK Associates Corp now owns 44,510 shares of the company’s stock valued at $564,000 after acquiring an additional 32,365 shares during the last quarter. CIBC Asset Management Inc lifted its stake in shares of UiPath by 30.6% during the 2nd quarter. CIBC Asset Management Inc now owns 13,564 shares of the company’s stock worth $172,000 after purchasing an additional 3,177 shares during the period. Rhumbline Advisers boosted its holdings in shares of UiPath by 2.6% during the second quarter. Rhumbline Advisers now owns 511,011 shares of the company’s stock worth $6,480,000 after purchasing an additional 12,836 shares during the last quarter. Finally, TD Asset Management Inc grew its position in shares of UiPath by 11.8% in the second quarter. TD Asset Management Inc now owns 32,200 shares of the company’s stock valued at $408,000 after purchasing an additional 3,400 shares during the period. Hedge funds and other institutional investors own 62.50% of the company’s stock.
About UiPath
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Recommended Stories
- Five stocks we like better than UiPath
- 5 Top Rated Dividend Stocks to Consider
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- How to Invest in Biotech Stocks
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.